Tumors related to the eye, also known as ocular tumors or eye cancer, can range from harmless to potentially life-threatening and can be primary (first discovered in the eye) or metastatic (spreading from another location).
Our team is focused on treating all types of childhood tumors and cancers affecting the eye. Retinoblastoma is the most common type of intraocular cancer found in children. We also diagnose and treat a wide range of other cancers affecting the eye. These include gliomas, astrocytomas, lymphomas, and rhabdomyosarcomas.
We also treat non-malignant tumors that affect the eye, including hamartomas.
Our expertise in ocular oncology
The Ocular Oncology Service is led by director of ocular oncology, vitreoretinal surgeon, and ocular oncologist Efren Gonzalez, MD, and director of medical therapies and pediatric oncologist Junne Kamihara, MD, PhD.
The following team members may be part of your child’s care team:
- pediatric ophthalmologists Ankoor Shah, MD, PhD, and Deborah VanderVeen, MD
- pediatric neuro-ophthalmologist Gena Heidary, MD, PhD
- pediatric oculoplastic surgeon Alexandra Elliott, MD
- pediatric interventional radiologist Darren Orbach, MD, PhD
- pediatric radiation oncologist Karen Marcus, MD
- pediatric oncologists
- pediatric cancer genetic counselors
We bring together a multidisciplinary team of experts from pediatric ophthalmology, oncology, neuro-interventional radiology, cancer genetics, oculoplastics, vitreoretinal surgery, and radiation oncology to provide exceptional, coordinated care to patients diagnosed with ocular oncology conditions. This permits us to not only treat the oncologic aspect of the disease but also provide care for the complete assessment and rehabilitation of the eye, allowing for a proper development of the visual system.
Why choose the Ocular Oncology Service
The Ocular Oncology Service represents the combined expertise of the Department of Ophthalmology at Boston Children’s Hospital and the Department of Pediatric Oncology at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. We are one of just a handful of pediatric programs in the world with a program dedicated entirely to eye problems caused by neoplastic conditions. Our team relies on a multidisciplinary approach to patient care and works closely to coordinate efforts with the specialized services listed above.
Our research program also offers unique access to clinical trials in which children can receive the newest treatments. A major focus of our program is the rapid translation of scientific discoveries to the bedside to benefit patients. Through this research, our physicians work to improve therapeutic approaches and outcomes for children with ocular tumors.
Get more in-depth information about the Ocular Oncology Service on the Dana-Farber/Boston Children’s website.